Home > Research > Publications & Outputs > Risk-Based Colposcopy for Cervical Precancer De...

Links

Text available via DOI:

View graph of relations

Risk-Based Colposcopy for Cervical Precancer Detection: A Cross-Sectional Multicenter Study in China

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Risk-Based Colposcopy for Cervical Precancer Detection: A Cross-Sectional Multicenter Study in China. / Xue, Peng; Seery, Samuel; Li, Qing et al.
In: Diagnostics, Vol. 12, No. 11, 2585, 25.10.2022.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Xue, P, Seery, S, Li, Q, Jiang, Y, Qiao, Y & Knez, J (ed.) 2022, 'Risk-Based Colposcopy for Cervical Precancer Detection: A Cross-Sectional Multicenter Study in China', Diagnostics, vol. 12, no. 11, 2585. https://doi.org/10.3390/diagnostics12112585

APA

Xue, P., Seery, S., Li, Q., Jiang, Y., Qiao, Y., & Knez, J. (Ed.) (2022). Risk-Based Colposcopy for Cervical Precancer Detection: A Cross-Sectional Multicenter Study in China. Diagnostics, 12(11), Article 2585. https://doi.org/10.3390/diagnostics12112585

Vancouver

Xue P, Seery S, Li Q, Jiang Y, Qiao Y, Knez J, (ed.). Risk-Based Colposcopy for Cervical Precancer Detection: A Cross-Sectional Multicenter Study in China. Diagnostics. 2022 Oct 25;12(11):2585. doi: 10.3390/diagnostics12112585

Author

Xue, Peng ; Seery, Samuel ; Li, Qing et al. / Risk-Based Colposcopy for Cervical Precancer Detection : A Cross-Sectional Multicenter Study in China. In: Diagnostics. 2022 ; Vol. 12, No. 11.

Bibtex

@article{1b62cb458388454ca1250d6e0e1ebe9d,
title = "Risk-Based Colposcopy for Cervical Precancer Detection: A Cross-Sectional Multicenter Study in China",
abstract = "Recently published guidelines depend upon screening for cervical precancer risk stratification; however, colposcopy provides key information. There is no data from developing countries that could be used comparatively. Therefore, we assessed the potential benefits of intercalating colposcopic impressions with screening results to detect cervical precancers through a multicenter, cross-sectional study of a Chinese population. Anonymized data from 6012 women with cytologic assessment, human papillomavirus (HPV) testing, colposcopic impressions, and histological results were analyzed. Univariate and multivariate analysis showed that high-grade squamous intraepithelial lesion (HSIL) cytology, HPV16/18+, and/or high-grade colposcopic impressions markedly increased cervical precancer risk, while high-grade colposcopic impressions were associated with the highest risk. The risk of cervical intraepithelial neoplasia grade 3 or worse (CIN3+) ranged from 0% for normal/benign colposcopic impressions, 19% increased risk of CIN3+, even in participants without HSIL+ cytology and/or HPV16/18+. Regardless of screening outcomes, normal/benign colposcopic impressions were associated with the lowest risk of CIN3+ (",
keywords = "Article, cervical cancer screening, colposcopy, precancer, risk assessment",
author = "Peng Xue and Samuel Seery and Qing Li and Yu Jiang and Youlin Qiao and Jure Knez",
year = "2022",
month = oct,
day = "25",
doi = "10.3390/diagnostics12112585",
language = "English",
volume = "12",
journal = "Diagnostics",
issn = "2075-4418",
publisher = "MDPI",
number = "11",

}

RIS

TY - JOUR

T1 - Risk-Based Colposcopy for Cervical Precancer Detection

T2 - A Cross-Sectional Multicenter Study in China

AU - Xue, Peng

AU - Seery, Samuel

AU - Li, Qing

AU - Jiang, Yu

AU - Qiao, Youlin

A2 - Knez, Jure

PY - 2022/10/25

Y1 - 2022/10/25

N2 - Recently published guidelines depend upon screening for cervical precancer risk stratification; however, colposcopy provides key information. There is no data from developing countries that could be used comparatively. Therefore, we assessed the potential benefits of intercalating colposcopic impressions with screening results to detect cervical precancers through a multicenter, cross-sectional study of a Chinese population. Anonymized data from 6012 women with cytologic assessment, human papillomavirus (HPV) testing, colposcopic impressions, and histological results were analyzed. Univariate and multivariate analysis showed that high-grade squamous intraepithelial lesion (HSIL) cytology, HPV16/18+, and/or high-grade colposcopic impressions markedly increased cervical precancer risk, while high-grade colposcopic impressions were associated with the highest risk. The risk of cervical intraepithelial neoplasia grade 3 or worse (CIN3+) ranged from 0% for normal/benign colposcopic impressions, 19% increased risk of CIN3+, even in participants without HSIL+ cytology and/or HPV16/18+. Regardless of screening outcomes, normal/benign colposcopic impressions were associated with the lowest risk of CIN3+ (

AB - Recently published guidelines depend upon screening for cervical precancer risk stratification; however, colposcopy provides key information. There is no data from developing countries that could be used comparatively. Therefore, we assessed the potential benefits of intercalating colposcopic impressions with screening results to detect cervical precancers through a multicenter, cross-sectional study of a Chinese population. Anonymized data from 6012 women with cytologic assessment, human papillomavirus (HPV) testing, colposcopic impressions, and histological results were analyzed. Univariate and multivariate analysis showed that high-grade squamous intraepithelial lesion (HSIL) cytology, HPV16/18+, and/or high-grade colposcopic impressions markedly increased cervical precancer risk, while high-grade colposcopic impressions were associated with the highest risk. The risk of cervical intraepithelial neoplasia grade 3 or worse (CIN3+) ranged from 0% for normal/benign colposcopic impressions, 19% increased risk of CIN3+, even in participants without HSIL+ cytology and/or HPV16/18+. Regardless of screening outcomes, normal/benign colposcopic impressions were associated with the lowest risk of CIN3+ (

KW - Article

KW - cervical cancer screening

KW - colposcopy

KW - precancer

KW - risk assessment

U2 - 10.3390/diagnostics12112585

DO - 10.3390/diagnostics12112585

M3 - Journal article

VL - 12

JO - Diagnostics

JF - Diagnostics

SN - 2075-4418

IS - 11

M1 - 2585

ER -